Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study

MLA

Mengkun Chen, et al. “Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.” Clinical Chemistry, vol. 68, June 2022, pp. 1084–93. EBSCOhost, https://doi.org/10.1093/clinchem/hvac096.

APA

Mengkun Chen, Ning Ding, Yejin Mok, Lena Mathews, Ron C Hoogeveen, Christie M Ballantyne, Lin Yee Chen, Josef Coresh, & Kunihiro Matsushita. (2022). Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study. Clinical Chemistry, 68, 1084–1093. https://doi.org/10.1093/clinchem/hvac096

Chicago

Mengkun Chen, Ning Ding, Yejin Mok, Lena Mathews, Ron C Hoogeveen, Christie M Ballantyne, Lin Yee Chen, Josef Coresh, and Kunihiro Matsushita. 2022. “Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.” Clinical Chemistry 68 (June): 1084–93. doi:10.1093/clinchem/hvac096.